Profund Advisors’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $374K | Sell |
26,723
-1,146
| -4% | -$16K | 0.01% | 576 |
|
|
2025
Q1 | $379K | Sell |
27,869
-866
| -3% | -$11.8K | 0.02% | 572 |
|
|
2024
Q4 | $586K | Buy |
28,735
+3,877
| +16% | +$79K | 0.02% | 434 |
|
|
2024
Q3 | $724K | Sell |
24,858
-4,515
| -15% | -$132K | 0.03% | 402 |
|
|
2024
Q2 | $682K | Sell |
29,373
-39,101
| -57% | -$908K | 0.03% | 403 |
|
|
2024
Q1 | $1.41M | Buy |
68,474
+14,799
| +28% | +$304K | 0.05% | 254 |
|
|
2023
Q4 | $1.15M | Buy |
53,675
+13,521
| +34% | +$290K | 0.05% | 300 |
|
|
2023
Q3 | $828K | Sell |
40,154
-6,321
| -14% | -$130K | 0.05% | 329 |
|
|
2023
Q2 | $1.37M | Sell |
46,475
-2,352
| -5% | -$69.4K | 0.07% | 236 |
|
|
2023
Q1 | $1.12M | Buy |
48,827
+33,960
| +228% | +$782K | 0.07% | 274 |
|
|
2022
Q4 | $413K | Buy |
14,867
+1,905
| +15% | +$53K | 0.03% | 482 |
|
|
2022
Q3 | $398K | Buy |
12,962
+186
| +1% | +$5.71K | 0.03% | 458 |
|
|
2022
Q2 | $376K | Sell |
12,776
-1,478
| -10% | -$43.5K | 0.02% | 523 |
|
|
2022
Q1 | $459K | Sell |
14,254
-1,586
| -10% | -$51.1K | 0.02% | 623 |
|
|
2021
Q4 | $706K | Sell |
15,840
-1,813
| -10% | -$80.8K | 0.02% | 439 |
|
|
2021
Q3 | $891K | Buy |
17,653
+14,982
| +561% | +$756K | 0.03% | 396 |
|
|
2021
Q2 | $210K | Buy |
+2,671
| New | +$210K | 0.01% | 1323 |
|